J. B. Chemicals & Pharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 6/6
J. B. Chemicals & Pharmaceuticals 의 총 주주 지분은 ₹32.1B 이고 총 부채는 ₹816.4M, 이는 부채 대 자기자본 비율을 2.5% 로 가져옵니다. 총자산과 총부채는 각각 ₹40.3B 및 ₹8.2B 입니다. J. B. Chemicals & Pharmaceuticals 의 EBIT는 ₹8.1B 이며 이자보상배율은 33.1 입니다. ₹4.2B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
2.5%
부채 비율
₹816.40m
부채
| 이자 보상 비율 | 33.1x |
| 현금 | ₹4.17b |
| 주식 | ₹32.12b |
| 총 부채 | ₹8.17b |
| 총 자산 | ₹40.29b |
최근 재무 상태 업데이트
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16재무 상태 분석
단기부채: JBCHEPHARM 의 단기 자산 ( ₹19.1B )이 단기 부채( ₹6.2B ).
장기 부채: JBCHEPHARM 의 단기 자산( ₹19.1B )이 장기 부채( ₹2.0B ).
부채 대 자본 내역 및 분석
부채 수준: JBCHEPHARM 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: JBCHEPHARM 의 부채 대 자기자본 비율은 지난 5년간 3% 에서 2.5% 로 감소했습니다.
부채 범위: JBCHEPHARM 의 부채는 영업 현금 흐름 ( 912.6% )에 의해 잘 충당되었습니다.
이자 보장: JBCHEPHARM 의 부채에 대한 이자 지급은 EBIT( 33.1 x 적용 범위)로 잘 충당됩니다.